Innovation Ventures Search Results
Narrow Your Results
Filter
Technology PatentStatus
- All (4)
- Issued Patent (0)
- National Phase Entry (1)
- PCT Filing (1)
- Provisional Filing (1)
- US Non-Provisional Filing (1)
Technology Categories
- All (7)
- Diagnostics (1)
- Educational Tools and Consumer Products (0)
- Medical Devices (0)
- Other (0)
- Research Tools (0)
- Software (3)
- Therapeutics (4)
Technology Stage Of Development
- All Results (4)
- Cell and Gene Therapy (1)
- Organoids (0)
- Other Biologics and Macromolecules (0)
- Small Molecule (3)
- Vaccines (0)
Results (7)
Brain Function Mapping with Intracranial SEEG Using Event-related Spectral Modulations
This SEEG-based technique offers a safer, more precise method for functional brain mapping.
Multi-Frequency Encoded Source Imaging
A new imaging technology to localize and visualize electrical and/or magnetic signals in two or more frequency ranges.
Restoring acid-β-glucosidase activity by non-inhibitory small molecule chaperones
Restore GCase activity in the brain for Gaucher and Parkinson's
Small Molecule Inhibitors for Treating Demyelinating Diseases
Small molecules, targeting HDAC3, enhance myelin repair in demyelinating diseases and injuries
TOPS is an online family problem-solving treatment for pediatric traumatic brain injury (TBI)
TOPS is an online family problem-solving treatment for pediatric traumatic brain injury (TBI)
Therapeutic Protein Delivery Across the Blood-Brain Barrier
A delivery mechanism which allows large molecule therapeutics to trancytose the blood-brain barrier for treatment of neurological disorders.
Using Dantrolene to Treat Neuronopathic Gaucher Disease
Dantrolene is an antagonist of ryanodine receptors (Ryrs) and blocks Ryr-mediated endoplasmic reticulum calcium release. It is an FDA-approved drug.
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026
© 1999-2025 Cincinnati Children's Hospital Medical Center. All rights reserved.
